1. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. Issue 10297 (24th July 2021) Authors: Berdeja, Jesus G; Madduri, Deepu; Usmani, Saad Z; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D; Stewart, A Keith; Hari, Parameswaran; Htut, Myo; Lesokhin, Alexander; Deol, Abhinav; Munshi, Nikhil C; O'Donnell, Elizabeth; Avigan, David; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred... Journal: Lancet Issue: Volume 398:Issue 10297(2021) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma. Issue 1 (10th December 2021) Authors: Martin, Thomas; Krishnan, Amrita; Yong, Kwee; Weisel, Katja; Mehra, Maneesha; Nair, Sandhya; Qi, Keqin; Londhe, Anil; Diels, Joris; Crivera, Concetta; Jackson, Carolyn C.; Olyslager, Yunsi; Vogel, Martin; Schecter, Jordan M.; Banerjee, Arnob; Valluri, Satish; Usmani, Saad Z.; Berdeja, Jesus G.; J... Journal: EJHaem Issue: Volume 3:Issue 1(2022) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concomitant amplification of the MLL gene on a ring chromosome and a homogeneously staining region (hsr) in acute myeloid leukemia: mechanistic implications. Issue 5 (4th May 2017) Authors: Koka, Rima; Mainor, Candace B.; Banerjee, Arnob; Baer, Maria R.; Zou, Ying S. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 5(2017) Page Start: 1250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response. (22nd May 2016) Authors: Reiser, John; Banerjee, Arnob Other Names: Zhang Yi Academic Editor. Journal: Journal of immunology research Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy. Issue 2 (February 2018) Authors: Furusawa, Aki; Reiser, John; Sadashivaiah, Kavitha; Simpson, Haley; Banerjee, Arnob Journal: Journal of immunotherapy Issue: Volume 41:Issue 2(2018:Feb./Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. (3rd October 2021) Authors: Martin, Tom; Usmani, Saad Z.; Schecter, Jordan M.; Vogel, Martin; Jackson, Carolyn C.; Deraedt, William; Tian, Hong; Yeh, Tzu-min; Banerjee, Arnob; Pacaud, Lida; Garrett, Ashraf; Haltner, Anja; Cameron, Chris; Van Sanden, Suzy; Diels, Joris; Valluri, Satish; Samjoo, Imtiaz A. Journal: Current medical research and opinion Issue: Volume 37:Number 10(2021) Page Start: 1779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study. Issue 10301 (21st August 2021) Authors: Usmani, Saad Z; Garfall, Alfred L; van de Donk, Niels W C J; Nahi, Hareth; San-Miguel, Jesus F; Oriol, Albert; Rosinol, Laura; Chari, Ajai; Bhutani, Manisha; Karlin, Lionel; Benboubker, Lotfi; Pei, Lixia; Verona, Raluca; Girgis, Suzette; Stephenson, Tara; Elsayed, Yusri; Infante, Jeffrey; Goldber... Journal: Lancet Issue: Volume 398:Issue 10301(2021) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. (2nd January 2023) Authors: Martin, Tom; Usmani, Saad Z.; Schecter, Jordan M.; Roccia, Tito; Jackson, Carolyn C.; Deraedt, William; Yeh, Tzu-min; Banerjee, Arnob; Pacaud, Lida; Garrett, Ashraf; Bartlett, Meaghan; Haltner, Anja; Van Sanden, Suzy; Diels, Joris; Valluri, Satish; Samjoo, Imtiaz A. Journal: Current medical research and opinion Issue: Volume 39:Number 1(2023) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗